Results 271 to 280 of about 53,707 (310)

[Conjugated vaccines].

Revue medicale de Bruxelles, 2002
Conjugate vaccines extend the vaccinal prevention for children to more diseases. Conjugating the capsular polysaccharide to a carrier protein transforms a T-independent antigen in a T-dependent, allowing protection of the children (before 2 years of age) against Haemophilus influenzae type b, meningococcal C and pneumococcal infections.
B, Swennen, J, Sternon
openaire   +1 more source

Immunogenicity of pneumococcal conjugate vaccines

The Pediatric Infectious Disease Journal, 2000
Prevention of pneumococcal infections is a public health priority because of the high impact of the disease and because of the increasing problems due to antimicrobial resistance. Traditional vaccines, consisting of purified capsular polysaccharides (PSs) of Streptococcus pneumoniae, are not immunogenic in young children.
openaire   +2 more sources

Conjugate vaccines: practice and theory

Springer Seminars in Immunopathology, 1993
Conjugate vaccines have already had a major impact on vaccination of infants against H. influenzae type b. The impact of conjugate vaccines will continue to grow as we apply this technology to other important diseases. The design of these vaccines will become more efficient and rational as we continue to understand the various facets and immunological ...
openaire   +2 more sources

[Conjugated vaccines].

Therapie, 2005
Encapsulated bacterial pathogens (e.g. Haemophilus influenzae type b [Hib], Neisseria meningitidis, or Streptococcus pneumoniae) target infants and young children who have lost any protective anti-capsular antibodies supplied maternally and whose immune systems are ineffective against T-independent antigens such as the polysaccharides of the capsule ...
openaire   +1 more source

A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children

Expert Review of Vaccines, 2022
Bruce A Mungall, Bernard Hoet, Javier Nieto Guevara   +2 more
exaly  

Conjugate Hib vaccines

The Lancet, 2003
Mark, Steinhoff, David, Goldblatt
openaire   +2 more sources

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

Vaccine, 2021
Mariano Young, Daniel A Scott, Kathrin U Jansen   +2 more
exaly  

Conjugate vaccines and autism

Medical Hypotheses, 2011
openaire   +2 more sources

Pneumococcal conjugate vaccines

The Pediatric Infectious Disease Journal, 2000
openaire   +2 more sources

Meningococcal group A, C, Y and W-135 conjugate vaccine

Nature Reviews Drug Discovery, 2010
Lee H Harrison
exaly